Michael P. Dillon is CSO & VP at IDEAYA Biosciences, Inc. (IDYA). They have made 7 open-market trades across 1 company since 2021, most recently 2021-10-04.
CIK 0001777415
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IDYA | 78,789 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2021-10-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDYA | SELL · 10b5-1 | 2021-10-04 | 2021-10-07 | $26.36 | $40K | -9.8% | -6.7% | -20.2% |
| IDYA | SELL | 2021-09-07 | 2021-09-09 | $27.41 | $622K | +1.8% | -2.7% | -11.3% |
| IDYA | SELL | 2021-09-02 | 2021-09-07 | $25.09 | $251K | -2.9% | -8.3% | -24.3% |
| IDYA | SELL | 2021-08-09 | 2021-08-11 | $22.98 | $264K | +12.0% | +20.1% | +4.3% |
| IDYA | SELL | 2021-07-27 | 2021-07-29 | $25.15 | $252K | -2.2% | -2.0% | -7.6% |
| IDYA | SELL · 10b5-1 | 2021-07-06 | 2021-07-08 | $22.24 | $33K | +17.9% | +34.0% | +49.3% |
| IDYA | SELL | 2021-06-16 | 2021-06-17 | $22.49 | $200K | -6.0% | -14.9% | +15.7% |
| IDYA | SELL · 10b5-1 | 2021-06-07 | 2021-06-09 | $20.22 | $30K | +4.2% | -18.5% | +24.8% |
| IDYA | SELL | 2021-05-11 | 2021-05-13 | $20.22 | $101K | +6.8% | +19.3% | +21.4% |
| IDYA | SELL | 2021-02-09 | 2021-02-10 | $20.74 | $207K | -13.1% | +8.4% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.